Physician profile
Bruce E Bosse
NPI 1487720967
$877.33
in general payments reported to CMS, 2019-2025
11 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $129 · 2021: $13.56 · 2022: $38.35 · 2023: $147 · 2024: $184 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.47 | 2021-2025 | Qulipta |
| Supernus Pharmaceuticals, INC. | $123.06 | 2019-2020 | |
| Biogen, INC. | $56.99 | 2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $36.77 | 2020 | |
| Boston Scientific Corporation | $26.25 | 2022 | |
| Genentech USA, INC. | $20.81 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.70 | 2020 | |
| Ge Healthcare | $18.74 | 2019 | |
| Medtronic Vascular, INC. | $13.19 | 2019 | |
| Amgen INC. | $12.10 | 2022 | |
| Allergan, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Bosse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.